Stay updated on Fazirsiran in AATD Liver Disease Clinical Trial
Sign up to get notified when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.

Latest updates to the Fazirsiran in AATD Liver Disease Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor site update or patch. No substantive study details or data were altered.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedClinicalTrials.gov’s page footer was updated to reflect a new site release revision (from v3.5.2 to v3.5.3). This represents a technical/version update to the website interface rather than a change to the study record.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision: v3.5.2.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now includes Alpha-1-antitrypsin deficiency as a topic and adds a Genetic and Rare Diseases Information Center resource under Resources.SummaryDifference0.2%

- Check51 days agoChange DetectedRemoved Alpha 1-antitrypsin deficiency and the Genetic and Rare Diseases Information Center resources from the page.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed. This indicates a new version of the study documents (likely protocol/SPA) has been issued.SummaryDifference0.1%

Stay in the know with updates to Fazirsiran in AATD Liver Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.